Our analysis of clinical cancer tissues revealed that CDH1/E-cad expression was downregulated only in a few types or subtypes of tumors among the large group of tumor types or subtypes examined; ILC happens to be a subtype of breast tumors in which E-cad expression was downregulated (Fig. 4F). Here, CCL27 is linked to breast neoplasm.